Visilizumab with tacrolimus and methotrexate for GvHD prevention after allogeneic hematopoietic cell transplantation from mismatched unrelated donors
Crossref DOI link: https://doi.org/10.1038/bmt.2016.330
Published Online: 2016-12-19
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Perez, L E
Fernandez, H
Ayala, E
Beato, F
Neuger, A
Pidala, J
Schell, M J
Anasetti, C
Text and Data Mining valid from 2016-12-19
Version of Record valid from 2016-12-19
Article History
First Online: 19 December 2016
Competing interests
: The authors declare no conflict of interest.